{
    "code": "02020943",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02020943",
    "time": "2020-02-25 12:35:05",
    "許可證字號": "衛署藥輸字第020943號",
    "註銷狀態": "已註銷",
    "註銷日期": "105\/05\/30",
    "註銷理由": "許可證已逾有效期",
    "有效日期": "104\/06\/10",
    "發證日期": "84\/06\/10",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202094307",
    "中文品名": "雷得治注射液",
    "英文品名": "LASTET INJECTION",
    "適應症": "抗癌症",
    "劑型": "270注射劑",
    "包裝": "安瓿 盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "02輸　入",
        "申請商名稱": "1435301100  臺灣日化股份有限公司",
        "申請商地址": "台北市中正區忠孝東路二段88號9樓",
        "主製造廠": ""
    },
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1012001000",
            "成分名稱": "ETOPOSIDE",
            "含量描述": "100",
            "含量": "100.0000000000",
            "單位": "ML"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Lastet藥品外觀-104-09-25(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02020943&Seq=002&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Lastet Injection中文仿單PDF檔-103-02-07.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02020943&Seq=001&Type=9"
        },
        {
            "title": "雷得治注射液-變更後背面-103-02-07.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02020943&Seq=002&Type=8"
        }
    ]
}